News

November 2, 2021

Enteris BioPharma Publishes White Paper on Best Practices in the Manufacturing of HPAPI Solid Oral Drug Products

Paper Examines the Opportunities and Challenges in Working with High Potency APIs Boonton, NJ, November 02, 2021  — Enteris BioPharma, Inc., a biotechnology company developing innovative drug […]
October 26, 2021

Enteris BioPharma
to Participate in the Partnership Opportunities in Drug Delivery (PODD)
2021 Conference

Boonton, NJ, October 26, 2021  — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of […]
October 13, 2021

Enteris BioPharma to Participate in the American Association of Pharmaceutical Scientists (AAPS) 2021 PHARMSCI 360 Conference

Boonton, NJ, October 13, 2021  — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of […]
September 29, 2021

Enteris BioPharma Announces Successful Completion of Phase 1 Clinical Trial of Optimized Peptelligence® Oral Leuprolide

Data indicates optimized Peptelligence® oral leuprolide formulation delivers comparable or greater drug levels than subcutaneous or depot injection   Boonton, NJ, September 29, 2021  — Enteris BioPharma, […]
August 23, 2021

Enteris BioPharma Receives 2021 Best of Boonton Award

Enteris recognized for the third consecutive year in the Pharmaceutical Company category   Boonton, NJ, August 23, 2021  — Enteris BioPharma, Inc., a biotechnology company developing innovative […]
June 15, 2021

Enteris BioPharma to Host Webinar on High Potency Active Pharmaceutical Ingredients in Oral Drug Development

On June 29 at 1pm ET, Co-Hosts Josh Stephens and Angela Consalvo Will Share Knowledge and Expertise on Selecting CDMOs for HPAPI and SOD Manufacturing   […]
June 11, 2021

SWK Holdings’ Subsidiary, Enteris BioPharma, Receives $10 Million Milestone Payment from Cara Therapeutics

Third milestone payment related to the development of Oral KORSUVA™   Dallas, TX, June 11, 2021  — SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty […]

KNOWLEDGE CENTER

Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.

LEARN MORE

KNOWLEDGE CENTER

Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.

LEARN MORE